前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービス
文献複写のお申込み
JDreamⅢ複写サービスのご利用が初めての方
学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202002220259621071   整理番号：20A1949665

PD-L1/L2蛋白質レベルは古典的ホジキンリンパ腫の腫瘍細胞からのトロゴサイトーシスを介して単球に急速に増加する【JST・京大機械翻訳】

PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma
著者 (28件)：
Kawashima Masaharu
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Kawashima Masaharu
(Division of Clinical Oncology and Hematology, Jikei University School of Medicine, Minato-ku, Tokyo, Japan)
, 
Carreras Joaquim
(Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa, Japan)
, 
Higuchi Hiroshi
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Higuchi Hiroshi
(Research Institute of Science and Technology, Tokai University, Hiratsuka, Kanagawa, Japan)
, 
Kotaki Ryutaro
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Hoshina Takahiro
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Hoshina Takahiro
(Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan)
, 
Okuyama Kazuki
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Suzuki Naoto
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Suzuki Naoto
(Department of Biosciences, School of Science, Kitasato University, Sagamihara, Kanagawa, Japan)
, 
Suzuki Naoto
(Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan)
, 
Kakizaki Masatoshi
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Miyatake Yuji
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Ando Kiyoshi
(Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan)
, 
Nakayama Masafumi
(Frontier Research Institute for Interdisciplinary Sciences, Tohoku University, Aoba-ku, Sendai, Japan)
, 
Umezu Shinjiro
(Department of Modern Mechanical Engineering, Waseda University, Shinjuku-ku, Tokyo, Japan)
, 
Horie Ryouichi
(Division of Hematology, Department of Laboratory Sciences, School of Allied Health Sciences, Kitasato University, Sagamihara, Kanagawa, Japan)
, 
Higuchi Yuriko
(Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan)
, 
Katagiri Koko
(Department of Biosciences, School of Science, Kitasato University, Sagamihara, Kanagawa, Japan)
, 
Goyama Susumu
(Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan)
, 
Kitamura Toshio
(Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan)
, 
Chamoto Kenji
(Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
, 
Yano Shingo
(Division of Clinical Oncology and Hematology, Jikei University School of Medicine, Minato-ku, Tokyo, Japan)
, 
Nakamura Naoya
(Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa, Japan)
, 
Kotani Ai
(Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan)
, 
Kotani Ai
(Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Saitama, Japan)
, 
Kotani Ai
(AMED-PRIME, Japan Agency for Medical Research and Development, Tokyo, Japan)

資料名：
Leukemia  (Leukemia)

巻： 34  号： 9  ページ： 2405-2417  発行年： 2020年 
JST資料番号： W4691A  ISSN： 0887-6924  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

Copyright (c) 2009 Japan Science and Technology Agency. All Rights Reserved

TOP

BOTTOM